IMMUNOGENICITY AND TOXICITY OF COVID-19 VACCINE CANDIDATE PROTEIN SUBUNIT PLATFORM RRBD SPIKE SARS-COV-2 IN BALB/C MICE
The development of a safe and effective SARS-CoV-2 vaccine is continuing to help overcome the COVID-19 pandemic. Several platforms, including the viral protein subunit platform, have been developed. ITB’s merah putih vaccine team has developed a recombinant Receptor Binding Domain (RBD) protein in E...
Saved in:
Main Author: | Aghniya Safitri, Intan |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/67667 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
IMMUNOGENICITY OF MULTIEPITOPE VACCINE CANDIDATE SPIKE AND NSP3 PROTEIN FUSION SARS-COV-2 IN BALB/C MICE
by: Meliana Shani, Annisa -
IMMUNOGENICITY AND SAFETY OF A MUTIEPITOP PEPTIDE-BASED VACCINE CANDIDATE BASED ON SARS-COV-2 SPIKE AND NSP3 FUSION IN BALB/C MICE
by: Rofiqoh, Afifatur -
Immunogenicity and efficacy of recombinant subunit SARS-CoV-2 vaccine candidate in the Syrian hamster model
by: Shanmugaraj B.
Published: (2023) -
Polymersomes as Stable Nanocarriers for a Highly Immunogenic and Durable SARS-CoV-2 Spike Protein Subunit Vaccine
by: Lam, Jian Hang, et al.
Published: (2022) -
The STING Ligand and Delivery System Synergistically Enhance the Immunogenicity of an Intranasal Spike SARS-CoV-2 Vaccine Candidate
by: Tuksin Jearanaiwitayakul, et al.
Published: (2022)